Enara Bio has snagged $32.5 million in a Series B fundraise, backed in part by Pfizer’s venture arm, to help develop a preclinical pipeline of …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”) proudly announces a milestone accomplishment from its
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases,
Johnson & Johnson wants to change the status quo in medical illustrations with more Black, brown and indigenous depictions. Its “Illustrate Change” campaign is centered